Journal article
The relationship between memory complaints, perceived quality of life and mental health in apolipoprotein eε4 carriers and non-carriers
HR Sohrabi, KA Bates, M Rodrigues, K Taddei, G Martins, SM Laws, NT Lautenschlager, SS Dhaliwal, JK Foster, RN Martins
Journal of Alzheimer S Disease | Published : 2009
Abstract
Apolipoprotein E ε4 (APOE-ε4) is a major genetic risk factor for Alzheimer's disease. In this study, we addressed the question of whether possession of the APOE-ε4 allele results in adverse effects on perceived health-related quality of life (HRQL) and on symptoms of depression and anxiety in people with subjective memory complaints (SMC). 138 healthy, community-dwelling elderly volunteers, aged 52 to 85, were assessed for HRQL, depression, and anxiety. The participants were classified as i) APOE-ε4 carriers or ii) non-carriers with a) SMC or b) without memory complaints. The possible interactions of APOE genotype, gender, and SMC on HRQL, depression, and anxiety were investigated statistica..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
This project was supported by the National Health and Medical Research Council (Australia), the McCusker Foundation for Alzheimer's Disease Research, Hollywood Private Hospital, National Institutes of Health (project ID: 52070400), and by a University of Western Australia postgraduate scholarship awarded to the first author (HRS). Jonathan Foster has received lecture fees from GST and Pfizer, and Ralph Martins owns stock in Alzhyme.